DLH (DLHC)


Market Price (8/8/2026): $4.82 | Market Cap: $69.9 MilSector: Industrials | Industry: Diversified Support Services

DLH (DLHC)


Market Price (8/8/2026): $4.82
Market Cap: $69.9 Mil
Sector: Industrials
Industry: Diversified Support Services

Investment Highlights Why It Matters Detailed financial logic regarding cash flow yields vs trend-riding momentum.

0

Attractive yield
FCF Yield is 20%

Low stock price volatility
Vol 12M is 37%

Megatrend and thematic drivers
Megatrends include Digital Health & Telemedicine, Cybersecurity, and Sustainable Resource Management. Themes include Health Data Analytics, Show more.

Weak multi-year price returns
2Y Excs Rtn is -98%, 3Y Excs Rtn is -126%

Not profitable at operating income level
Op Inc LTMOperating Income, Last Twelve Months is -0.3 Mil, Op Mgn LTMOperating Margin = Operating Income / Revenue Reflects profitability before taxes and before impact of capital structure (interest payments). is -0.1%

Debt is significant
Net D/ENet Debt/Equity. Debt net of cash. Negative indicates net cash. Equity is taken as the Market Capitalization is 202%

Weak revenue growth
Rev Chg LTMRevenue Change % Last Twelve Months (LTM) is -30%, Rev Chg 3Y AvgRevenue Change % averaged over trailing 3 years is -7.5%, Rev Chg QQuarterly Revenue Change % is -47%

Yield minus risk free rate is negative
ERPEquity Risk Premium (ERP) = Total Yield - Risk Free Rate, Reflects the premium above risk free assets offered by the investment. is -35%

Key risks
DLHC key risks include [1] revenue decline from contract conversions and losses to small business set-asides, Show more.

0 Attractive yield
FCF Yield is 20%
1 Low stock price volatility
Vol 12M is 37%
2 Megatrend and thematic drivers
Megatrends include Digital Health & Telemedicine, Cybersecurity, and Sustainable Resource Management. Themes include Health Data Analytics, Show more.
3 Weak multi-year price returns
2Y Excs Rtn is -98%, 3Y Excs Rtn is -126%
4 Not profitable at operating income level
Op Inc LTMOperating Income, Last Twelve Months is -0.3 Mil, Op Mgn LTMOperating Margin = Operating Income / Revenue Reflects profitability before taxes and before impact of capital structure (interest payments). is -0.1%
5 Debt is significant
Net D/ENet Debt/Equity. Debt net of cash. Negative indicates net cash. Equity is taken as the Market Capitalization is 202%
6 Weak revenue growth
Rev Chg LTMRevenue Change % Last Twelve Months (LTM) is -30%, Rev Chg 3Y AvgRevenue Change % averaged over trailing 3 years is -7.5%, Rev Chg QQuarterly Revenue Change % is -47%
7 Yield minus risk free rate is negative
ERPEquity Risk Premium (ERP) = Total Yield - Risk Free Rate, Reflects the premium above risk free assets offered by the investment. is -35%
8 Key risks
DLHC key risks include [1] revenue decline from contract conversions and losses to small business set-asides, Show more.

DLHC in ETFs

Weight = DLHC's share of each fund

DFAS0.00%

Valuation & Metrics

Price Chart

Why The Stock Moved

Qualitative Assessment

AI Analysis | Feedback

Updated on 8/1/2026

DLH (DLHC) stock has lost about 15% since 4/30/2026 because of the following key factors:

1. DLH Holdings Corp. (DLHC) experienced a significant miss in its fiscal Q3 2026 financial results, which ended on June 30, 2026. The company reported a net loss of $16.8 million, or $(1.16) diluted earnings per share, substantially missing analyst estimates of a loss of $0.17 per share by $0.99. Revenue for the quarter was $44.2 million, falling short of the $53 million forecast by 16.6% and representing a 47% decline year-over-year from $83.3 million in the prior-year quarter. Additionally, Adjusted EBITDA decreased by 58% to $3.4 million, with the margin compressing to 7.6%, below management's long-term target of 9%-10%.

2. The substantial revenue decline was primarily due to the transition of legacy prime contracts, specifically the VA CMOP (Consolidated Mail Outpatient Pharmacy) program, to small-business set-aside contractors. This program's revenue fell from $27.0 million to $6.3 million in fiscal Q3 2026 year-over-year, as the company completed its planned exit from this major contract. This shift resulted in a smaller, technology-driven revenue base, with the "Technology-Powered Solutions" segment generating $38.0 million, down from $56.4 million in the prior year. The company's backlog also decreased to $408.5 million as of June 30, 2026, from $514.3 million at September 30, 2025, reflecting these program transitions.

Show more
Updated on 8/1/2026

DLH (DLHC) stock has lost about 15% since 4/30/2026 because of the following key factors:

1. DLH Holdings Corp. (DLHC) experienced a significant miss in its fiscal Q3 2026 financial results, which ended on June 30, 2026. The company reported a net loss of $16.8 million, or $(1.16) diluted earnings per share, substantially missing analyst estimates of a loss of $0.17 per share by $0.99. Revenue for the quarter was $44.2 million, falling short of the $53 million forecast by 16.6% and representing a 47% decline year-over-year from $83.3 million in the prior-year quarter. Additionally, Adjusted EBITDA decreased by 58% to $3.4 million, with the margin compressing to 7.6%, below management's long-term target of 9%-10%.

2. The substantial revenue decline was primarily due to the transition of legacy prime contracts, specifically the VA CMOP (Consolidated Mail Outpatient Pharmacy) program, to small-business set-aside contractors. This program's revenue fell from $27.0 million to $6.3 million in fiscal Q3 2026 year-over-year, as the company completed its planned exit from this major contract. This shift resulted in a smaller, technology-driven revenue base, with the "Technology-Powered Solutions" segment generating $38.0 million, down from $56.4 million in the prior year. The company's backlog also decreased to $408.5 million as of June 30, 2026, from $514.3 million at September 30, 2025, reflecting these program transitions.

3. The net loss for fiscal Q3 2026 was further amplified by a significant non-cash valuation allowance and restructuring costs. The reported $16.8 million net loss included a $10.4 million valuation allowance against deferred tax assets. The quarter also involved approximately $3.3 million in costs related to "cost-scaling actions" and a "broad restructuring effort" aimed at aligning the operating structure with expected near-term revenue volumes following the contract transitions.

Show less
Holding a concentrated position? Know your true downside before the momentum shifts.
Protect Your Wealth →

Stock Movement Drivers

Fundamental Drivers

The -17.2% change in DLHC stock from 4/30/2026 to 8/7/2026 was primarily driven by a -21.4% change in the company's Total Revenues ($ Mil).
(LTM values as of)43020268072026Change
Stock Price ($)5.824.82-17.2%
Change Contribution By: 
Total Revenues ($ Mil)323254-21.4%
P/S Multiple0.30.35.4%
Shares Outstanding (Mil)14140.0%
Cumulative Contribution-17.2%

LTM = Last Twelve Months as of date shown

Market Drivers

4/30/2026 to 8/7/2026
ReturnCorrelation
DLHC-17.2% 
Market (SPY)7.6%-18.6%
Sector (XLI)6.1%-15.3%

Fundamental Drivers

The -15.6% change in DLHC stock from 1/31/2026 to 8/7/2026 was primarily driven by a -26.4% change in the company's Total Revenues ($ Mil).
(LTM values as of)13120268072026Change
Stock Price ($)5.714.82-15.6%
Change Contribution By: 
Total Revenues ($ Mil)344254-26.4%
P/S Multiple0.20.315.5%
Shares Outstanding (Mil)1414-0.7%
Cumulative Contribution-15.6%

LTM = Last Twelve Months as of date shown

Market Drivers

1/31/2026 to 8/7/2026
ReturnCorrelation
DLHC-15.6% 
Market (SPY)12.1%0.3%
Sector (XLI)12.2%6.4%

Fundamental Drivers

The -14.1% change in DLHC stock from 7/31/2025 to 8/7/2026 was primarily driven by a -32.8% change in the company's Total Revenues ($ Mil).
(LTM values as of)73120258072026Change
Stock Price ($)5.614.82-14.1%
Change Contribution By: 
Total Revenues ($ Mil)377254-32.8%
P/S Multiple0.20.328.7%
Shares Outstanding (Mil)1414-0.7%
Cumulative Contribution-14.1%

LTM = Last Twelve Months as of date shown

Market Drivers

7/31/2025 to 8/7/2026
ReturnCorrelation
DLHC-14.1% 
Market (SPY)23.4%6.5%
Sector (XLI)23.1%5.9%

Fundamental Drivers

The -52.0% change in DLHC stock from 7/31/2023 to 8/7/2026 was primarily driven by a -39.1% change in the company's P/S Multiple.
(LTM values as of)73120238072026Change
Stock Price ($)10.054.82-52.0%
Change Contribution By: 
Total Revenues ($ Mil)306254-17.1%
P/S Multiple0.50.3-39.1%
Shares Outstanding (Mil)1414-5.1%
Cumulative Contribution-52.0%

LTM = Last Twelve Months as of date shown

Market Drivers

7/31/2023 to 8/7/2026
ReturnCorrelation
DLHC-52.0% 
Market (SPY)74.9%24.5%
Sector (XLI)74.7%26.3%

Return vs. Risk

Price Returns Compared

 202120222023202420252026Total [1]
Returns
DLHC Return122%-43%33%-49%-30%-14%-48%
Peers Return-1%17%13%9%7%-5%44%
S&P 500 Return27%-19%24%23%16%13%105%

Monthly Win Rates [3]
DLHC Win Rate67%42%67%25%33%25% 
Peers Win Rate58%57%60%65%55%50% 
S&P 500 Win Rate75%42%67%75%67%50% 

Max Drawdowns [4]
DLHC Max Drawdown-24%-44%-33%-57%-66%-24% 
Peers Max Drawdown-21%-21%-17%-29%-29%-39% 
S&P 500 Max Drawdown-5%-25%-10%-8%-19%-9% 


[1] Cumulative total returns since the beginning of 2021
[2] Peers: LDOS, BAH, SAIC, CACI, MMS.
[3] Win Rate = % of calendar months in which monthly returns were positive
[4] Max drawdown represents maximum peak-to-trough decline within a year
[5] 2026 data is for the year up to 8/7/2026 (YTD)

How Low Can It Go

EventDLHCS&P 500
2025 US Tariff Shock
  % Loss-51.6%-18.8%
  % Gain to Breakeven106.6%23.1%
  Time to Breakeven76 days79 days
2023 SVB Regional Banking Crisis
  % Loss-30.4%-6.7%
  % Gain to Breakeven43.7%7.1%
  Time to Breakeven136 days31 days
2020 COVID-19 Crash
  % Loss-32.4%-33.7%
  % Gain to Breakeven47.9%50.9%
  Time to Breakeven21 days140 days
Q4 2018 Fed Policy Error / Growth Scare
  % Loss-27.2%-19.2%
  % Gain to Breakeven37.4%23.8%
  Time to Breakeven49 days105 days
2015-2016 China Devaluation / Global Growth Scare
  % Loss-12.1%-12.2%
  % Gain to Breakeven13.8%13.9%
  Time to Breakeven12 days62 days
2013 Taper Tantrum
  % Loss-15.9%-0.2%
  % Gain to Breakeven18.8%0.2%
  Time to Breakeven2 days1 days

Compare to LDOS, BAH, SAIC, CACI, MMS

In The Past

DLH's stock fell -51.6% during the 2025 US Tariff Shock. Such a loss loss requires a 106.6% gain to breakeven.

Preserve Wealth

Limiting losses and compounding gains is essential to preserving wealth.

Asset Allocation

Actively managed asset allocation strategies protect wealth. Learn more.

EventDLHCS&P 500
2025 US Tariff Shock
  % Loss-51.6%-18.8%
  % Gain to Breakeven106.6%23.1%
  Time to Breakeven76 days79 days
2023 SVB Regional Banking Crisis
  % Loss-30.4%-6.7%
  % Gain to Breakeven43.7%7.1%
  Time to Breakeven136 days31 days
2020 COVID-19 Crash
  % Loss-32.4%-33.7%
  % Gain to Breakeven47.9%50.9%
  Time to Breakeven21 days140 days
Q4 2018 Fed Policy Error / Growth Scare
  % Loss-27.2%-19.2%
  % Gain to Breakeven37.4%23.8%
  Time to Breakeven49 days105 days
2011 US Debt Ceiling Crisis & European Contagion
  % Loss-49.8%-17.9%
  % Gain to Breakeven99.2%21.8%
  Time to Breakeven840 days123 days
2010 Eurozone Sovereign Debt Crisis / Flash Crash
  % Loss-50.0%-15.4%
  % Gain to Breakeven100.0%18.2%
  Time to Breakeven336 days125 days
2008-2009 Global Financial Crisis
  % Loss-90.3%-53.4%
  % Gain to Breakeven927.5%114.4%
  Time to Breakeven4312 days1085 days

Compare to LDOS, BAH, SAIC, CACI, MMS

In The Past

DLH's stock fell -51.6% during the 2025 US Tariff Shock. Such a loss loss requires a 106.6% gain to breakeven.

Preserve Wealth

Limiting losses and compounding gains is essential to preserving wealth.

Asset Allocation

Actively managed asset allocation strategies protect wealth. Learn more.

About DLH (DLHC)

DLH Holdings Corp. (DLHC) is a government contractor specializing in technology-enabled business process outsourcing, program management solutions, and public health research and analytics. The company provides critical support to federal agencies by helping them manage complex health-related programs, data, and IT infrastructure.

DLHC's services are primarily geared towards the federal health sector, offering a range of specialized solutions. These include defense and veterans' health services, such as healthcare technology, logistics, and program support for organizations like the Department of Veterans Affairs (VA) and the Defense Health Agency. Additionally, DLH provides human services solutions, encompassing electronic medical records migration, data collection and management, and IT system architecture and maintenance. Its public health and life sciences offerings include clinical trials, epidemiology studies, and health promotion strategies for underserved and at-risk communities.

The company's primary market is the U.S. federal health services, with key customers including various branches of the military health system, the VA, and other federal entities involved in health research and program delivery. DLH Holdings Corp. leverages its expertise to support national health initiatives and improve service delivery across these critical government sectors.

AI Analysis | Feedback

Here are a few analogies for DLH Holdings Corp.:

  • A specialized Booz Allen Hamilton for federal health agencies.
  • Like Leidos, but focused exclusively on healthcare and technology solutions for the U.S. government.

AI Analysis | Feedback

  • Defense and Veterans' Health Solutions: Provides comprehensive healthcare, technology, and logistics solutions primarily to the VA and other federal defense health agencies.
  • Human Services and Solutions: Delivers a range of services including monitoring and evaluation, electronic medical records migration, data management, and IT system support for federal human services programs.
  • Public Health and Life Sciences Services: Offers specialized services such as clinical trials, epidemiology studies, disease prevention, and health promotion campaigns to federal health initiatives.

AI Analysis | Feedback

Major Customers of DLH Holdings Corp. (DLHC)

DLH Holdings Corp. primarily serves the federal health services market. Its major customers are various U.S. government agencies and departments:

  • VA (Department of Veterans Affairs)
  • Defense Health Agency
  • Tele-medicine and Advanced Technology Research Center
  • Navy Bureau of Medicine and Surgery
  • Army Medical Research and Material Command

AI Analysis | Feedback

null

AI Analysis | Feedback

Zachary Parker, President, CEO, and Director

Zachary Parker has served as DLH's President, Chief Executive Officer, and board director since 2010. During his tenure, he has spearheaded four strategic acquisitions: Danya International, Inc. (2016), Social & Scientific Systems, Inc. (2019), Irving Burton Associates, LLC (2020), and Grove Resource Solutions, Inc (2022), expanding DLH's service portfolio to include a broader range of technology-enabled Federal services and public health capabilities. Before joining DLH, Mr. Parker held leadership roles within Northrop Grumman Corporation, VT Group, GE Government Services (now Lockheed Martin), and VSE Corporation. Northrop Grumman Mission Systems & IT was acquired by Peraton in 2020, and GE Government Services was acquired by Lockheed Martin. He also served as President & VP-Business Development at VT Griffin Services, Inc. from 2008 to 2010 and as CEO at Brightlane.Com, Inc. He possesses over 25 years of government services leadership experience across the Department of Defense (DoD) and federal civilian markets.

Kathryn JohnBull, Chief Financial Officer

Kathryn JohnBull has served as the Chief Financial Officer and Treasurer at DLH Holdings Corp. since June 25, 2012. She has worked alongside DLH President and CEO Zach Parker for over a decade.

Mary Dowdall, President, Advanced Mission Services

Mary Dowdall is President of DLH's Advanced Mission Solutions (AMS) Operating Center, where she leads DLH's Military Health services portfolio, specializing in technology, systems engineering and integration, business solutions, and research and development. She has over 25 years of experience in strategic and tactical leadership of small to mid-size business operations and corporate goals. Her expertise includes program and project management mission support with the Department of Defense (DoD) Health Affairs (HA) and various Defense Health clients. Ms. Dowdall was the president of Irving Burton Associates (IBA) prior to its acquisition by DLH in 2020 and remained with DLH in leadership of the IBA organization.

Jeanine Christian, President, Public Health & Scientific Research

Jeanine Christian serves as the President of DLH's Public Health & Scientific Research operating unit. She is a senior executive with nearly 30 years of experience helping clients advance their public health goals. Before joining DLH in July 2020, she led a team of over 300 scientists, clinicians, researchers, and data analysts at Battelle Memorial Institute's Public Health Research Division. Prior to that, she was a Senior Study Director at Westat, where she directed large, complex public health research projects in areas such as alcohol and drug abuse, and social service programs.

Billy Burnett, President, National Security Programs

Billy Burnett serves as President of DLH's National Security Programs operations center, overseeing all defense and intelligence programs and leading operational and business development activities. He brings over 25 years of industry experience in client engagement, business development, program management, and systems engineering. Mr. Burnett first joined DLH through its subsidiary Grove Resource Solutions, Inc. in 2012. He is a Veteran of the U.S. Navy, having served from 1979 to 1987. Before his time at GRSi, he held roles at Atlas Executive Consultants, LLC, rKay Services Group, EMA/SAIC, and ManTech.

AI Analysis | Feedback

The key risks to DLH Holdings Corp. (DLHC) primarily stem from its financial leverage, dependence on federal contracts, and the challenges associated with integrating recent acquisitions.

  1. High Debt and Interest Coverage: DLH Holdings Corp. carries a significant amount of debt, with a reported US$162.2 million in debt as of December 2024 and a low interest coverage ratio of 1.4 times, indicating potential difficulty in covering interest expenses with its earnings before interest and taxes (EBIT). The company's debt-to-equity ratio was approximately 119%, and its interest payments were not well covered by EBIT at 0.9x coverage. This financial leverage is a concern, especially if the company's EBIT continues to decline.
  2. Dependence on Federal Government Contracts and Budgetary Changes: As a company primarily serving the federal health services market, DLH Holdings Corp. is exposed to risks related to government contract procurement processes, including intense competition for new business and re-competes for existing contracts. Risks also include potential changes in client budgetary priorities, the impact of government contract procurement issues (such as bid protests or small business set-asides), and contract termination risks. Furthermore, federal budget volatility poses a principal risk to the company's financial stability and growth prospects.
  3. Acquisition Integration Challenges: DLH Holdings Corp. engages in strategic acquisitions, such as the recent acquisition of GRSi in December 2022. Such acquisitions introduce risks that include the potential inability to realize the anticipated benefits, financial performance, and results from these integrations. Other challenges involve diverting management's attention from daily operations, managing larger and more widespread operations, and retaining both employees and customers of the acquired entities. Successful integration execution and achieving expected synergies are crucial for mitigating these risks.

AI Analysis | Feedback

Emergence of highly sophisticated artificial intelligence (AI) and automation solutions capable of performing data collection, management, analysis, program monitoring, and health research and analytics tasks with greater efficiency and lower cost, potentially reducing the need for DLH's human-intensive business process outsourcing and consulting services in the federal health market.

AI Analysis | Feedback

Addressable Markets for DLH Holdings Corp. (DLHC)

DLH Holdings Corp. primarily serves the federal health services market in the United States. The addressable markets for its main products and services in the U.S. region are detailed below:

Defense and Veterans' Health Solutions

  • The broader U.S. federal healthcare contracting market, which includes services for agencies like the Department of Defense (DoD) and the Department of Veterans Affairs (VA), represented approximately $105 billion in fiscal year 2023, based on federal healthcare spending comprising nearly 14% of over $750 billion in total federal contract obligations.
  • The U.S. defense market, encompassing contract spending by the Department of Defense (DoD), stood at USD 354.48 billion in 2026. Overall DoD contract obligations exceeded $470 billion in fiscal year 2023.
  • For the Department of Veterans Affairs (VA), total contract spending is projected to be $82 billion in 2025. Specifically, contract spending for veterans' medical services increased to $34.6 billion in fiscal year 2025.
  • Military logistical support and infrastructure, relevant to DLH's logistics solutions, sees the U.S. Department of Defense (DoD) allocating approximately $25 billion annually for military infrastructure and logistical support.

Human Services and IT Solutions

  • The U.S. federal civilian IT services market, which includes electronic medical records migration, data collection and management, and IT system architecture services, is estimated at $128 billion in 2025. The VA alone obligated over $25 billion for IT products and services from fiscal years 2017-2021.
  • The broader U.S. public sector consulting and advisory services market, which may include monitoring and evaluation and health assessments, was approximately $80 billion in 2023.

Public Health and Life Sciences Services

  • U.S. federal public health spending amounted to $35.5 billion in 2024.
  • Contract spending by the Department of Health and Human Services (HHS), which covers a wide array of public health and life sciences services, is projected to account for $128 billion, or 17%, of federal contract spending in 2025.
  • The overall U.S. life science market, which encompasses clinical trials, epidemiology studies, and health informatics, was valued at US$31.58 billion in 2025 and is expected to grow to US$35.39 billion in 2026.
  • The U.S. life science analytics market, directly relevant to health informatics analyses, was valued at USD 11.96 billion in 2025 and is projected to reach approximately USD 28.66 billion by 2034.

AI Analysis | Feedback

DLH Holdings Corp. (DLHC) anticipates future revenue growth over the next two to three years driven by several key factors within its federal health services market focus.

Here are 3-5 expected drivers of future revenue growth for DLH Holdings Corp.:

  1. Increased Federal Funding and Budget Stability: The recently enacted federal budget is expected to provide increased funding capacity and improved visibility for DLH's federal health agency clients. This reversal of previous funding reductions and enhanced budget clarity are anticipated to positively impact the company's organic growth initiatives and overall demand across its core markets.
  2. Digital Transformation and Modernization-Driven Awards: DLH is strategically positioned to secure new contracts related to digital transformation and modernization efforts within federal agencies. The company's expertise in areas such as cybersecurity, including Zero Trust applications, cloud migration, and artificial intelligence (AI) adoption, aligns with the federal government's priorities for modernizing its health systems.
  3. Expansion of Technology-Powered Solutions and New Contract Acquisitions: The company aims to expand its technology-powered solutions portfolio, targeting growth within its core technology sectors. While recent revenue has been affected by transitions to small business set-aside contracts, DLH expects to see increased bid opportunities and is focused on winning larger, broader contracts, including through IDIQ (Indefinite Delivery, Indefinite Quantity) and GWAC (Government-Wide Acquisition Contract) prime vehicles.
  4. Strategic Initiatives and Integration of Acquired Capabilities: Strategic acquisitions, such as the purchase of GRSi in December 2023, have significantly enhanced DLH's scale and digital capabilities. The company's growth strategy includes the ongoing integration of these acquired capabilities and a focus on cross-selling its cloud and cybersecurity services into existing legacy health contracts.

AI Analysis | Feedback

Capital Allocation Decisions (Last 3-5 Years)

Share Repurchases

  • DLH Holdings Corp. did not hold any treasury stock as of June 30, 2025, and September 30, 2024, indicating no significant share repurchases during this period.
  • An older share repurchase program authorized for up to $1,000,000 was approved on September 12, 2019, with no expiration date. However, recent filings suggest this program has not resulted in treasury stock being held in the last 3-5 years.

Share Issuance

  • The company granted 312,906 shares of restricted stock units during the nine months ended June 30, 2025.
  • During the nine months ended June 30, 2024, DLH Holdings Corp. granted 169,544 shares of restricted stock units.

Outbound Investments

  • DLH Holdings Corp. completed the acquisition of GRSi in 2022 for approximately $185 million, expanding its capabilities in cybersecurity, C5ISR, and digital modernization.

Capital Expenditures

  • DLH Holdings Corp. invested approximately $39 thousand in capital expenditures in the first quarter of fiscal year 2026.

Better Bets vs. DLH (DLHC)

Latest Trefis Analyses

TitleDate
0DASHBOARDS 
1DLH Earnings Notes12/16/2025
2Is DLH Stock Built to Withstand More Downside?10/17/2025
Title
0ARTICLES

Recent Active Movers

Peer Comparisons

Peers to compare with:

Financials

DLHCLDOSBAHSAICCACIMMSMedian
NameDLH Leidos Booz All.Science .CACI Int.Maximus  
Mkt Price4.82137.5776.05126.54644.4359.19101.30
Mkt Cap0.117.39.15.514.23.17.3
Rev LTM25417,63411,0937,2919,5685,2488,429
Op Inc LTM-02,0801,055579920579749
FCF LTM142,1631,116603780433692
FCF 3Y Avg231,645799482565224524
CFO LTM142,3001,203636887470761
CFO 3Y Avg231,800887515644303579

Growth & Margins

DLHCLDOSBAHSAICCACIMMSMedian
NameDLH Leidos Booz All.Science .CACI Int.Maximus  
Rev Chg LTM-29.5%3.4%-7.3%-2.9%10.9%-3.3%-3.1%
Rev Chg 3Y Avg-7.5%5.9%5.1%-1.9%12.6%3.0%4.0%
Rev Chg Q-46.9%7.2%-4.2%1.5%17.6%-5.1%-1.3%
QoQ Delta Rev Chg LTM-13.4%1.8%-1.1%0.4%4.4%-1.3%-0.4%
Op Inc Chg LTM-101.3%2.9%-23.1%4.7%20.4%12.0%3.8%
Op Inc Chg 3Y Avg-33.5%21.9%42.6%3.4%17.5%26.6%19.7%
Op Mgn LTM-0.1%11.8%9.5%7.9%9.6%11.0%9.6%
Op Mgn 3Y Avg4.1%11.2%10.1%7.3%9.0%9.9%9.4%
QoQ Delta Op Mgn LTM-2.6%-0.4%0.3%0.8%0.3%0.1%0.2%
CFO/Rev LTM5.5%13.0%10.8%8.7%9.3%8.9%9.1%
CFO/Rev 3Y Avg6.7%10.6%7.8%7.0%7.4%5.8%7.2%
FCF/Rev LTM5.5%12.3%10.1%8.3%8.2%8.3%8.3%
FCF/Rev 3Y Avg6.6%9.7%7.0%6.6%6.5%4.3%6.6%

Valuation

DLHCLDOSBAHSAICCACIMMSMedian
NameDLH Leidos Booz All.Science .CACI Int.Maximus  
Mkt Cap0.117.39.15.514.23.17.3
P/S0.31.00.80.81.50.60.8
P/Op Inc-257.88.38.69.615.55.48.5
P/EBIT-36.18.68.29.615.55.48.4
P/E-3.212.611.713.726.68.412.2
P/CFO5.07.57.68.716.16.77.6
Total Yield-30.9%9.2%11.6%8.6%3.8%14.0%8.9%
Dividend Yield0.0%1.2%3.1%1.2%0.0%2.2%1.2%
FCF Yield 3Y Avg22.3%10.2%8.1%9.1%5.6%6.3%8.6%
D/E2.00.40.50.50.40.60.5
Net D/E2.00.30.40.50.40.50.4

Returns

DLHCLDOSBAHSAICCACIMMSMedian
NameDLH Leidos Booz All.Science .CACI Int.Maximus  
1M Rtn-6.8%28.4%21.3%12.1%30.5%3.4%16.7%
3M Rtn-17.0%6.1%-0.5%35.2%34.0%-7.4%2.8%
6M Rtn-17.9%-28.3%-13.3%29.6%4.2%-20.4%-15.6%
12M Rtn-13.2%-20.7%-29.5%10.5%28.9%-23.1%-16.9%
3Y Rtn-54.6%46.7%-33.9%8.5%81.9%-22.4%-6.9%
1M Excs Rtn-8.0%26.2%17.6%8.5%30.5%1.6%13.0%
3M Excs Rtn-21.6%-0.6%-6.0%29.2%25.8%-16.4%-3.3%
6M Excs Rtn-32.3%-39.7%-22.8%17.2%-6.4%-37.7%-27.5%
12M Excs Rtn-35.6%-42.6%-52.4%-10.8%13.3%-41.8%-38.7%
3Y Excs Rtn-125.8%-27.4%-106.7%-64.1%9.8%-97.1%-80.6%

Comparison Analyses

null

Financials

Segment Financials

Revenue by Segment
$ Mil20252024202320222021
Single Segment344396376395246
Total344396376395246


Operating Income by Segment
$ Mil20052004200320022001
Staffing Services2    
Payroll Services22222
Corporate -6   
Medical Staffing 148 
Professional Employer Services   4-1
Temporary Staffing    8
Total4-35149


Assets by Segment
$ Mil20052004200320022001
Staffing Services20    
Payroll Services13240
Corporate 28   
Medical Staffing 61817 
Professional Employer Services   4034
Temporary Staffing    18
Total2137216153


Price Behavior

Price Behavior
Market Price$4.82 
Market Cap ($ Bil)0.1 
First Trading Date08/18/1995 
Distance from 52W High-26.6% 
   50 Days200 Days
DMA Price$5.33$5.70
DMA Trenddowndown
Distance from DMA-9.5%-15.4%
 3M1YR
Volatility33.4%36.6%
Downside Capture6.4920.55
Upside Capture-74.80-0.40
Correlation (SPY)-18.5%5.4%
DLHC Betas & Captures as of 7/31/2026

 1M2M3M6M1Y3Y
Beta-2.01-0.55-0.450.040.210.71
Up Beta-5.91-1.71-1.240.550.710.91
Down Beta-2.59-0.42-0.12-0.48-0.090.69
Up Capture-117%-67%-60%-14%3%13%
Bmk +ve Days11223567138427
Stock +ve Days10172453107338
Down Capture-13%18%6%32%33%93%
Bmk -ve Days11212859114326
Stock -ve Days11233263121383

[1] Upside and downside betas calculated using positive and negative benchmark daily returns respectively
Based On 1-Year Data
Annualized
Return
Annualized
Volatility
Sharpe
Ratio
Correlation
with DLHC
DLHC-13.4%36.5%-0.32-
Sector ETF (XLI)24.1%17.0%1.105.3%
Equity (SPY)23.3%12.8%1.365.3%
Gold (GLD)28.5%28.4%0.877.7%
Commodities (DBC)32.9%19.8%1.32-6.1%
Real Estate (VNQ)14.2%13.8%0.7214.9%
Bitcoin (BTCUSD)-44.2%42.9%-1.230.8%

Smart multi-asset allocation framework can stack odds in your favor. Learn How
Based On 5-Year Data
Annualized
Return
Annualized
Volatility
Sharpe
Ratio
Correlation
with DLHC
DLHC-14.3%47.8%-0.16-
Sector ETF (XLI)14.0%17.6%0.6224.8%
Equity (SPY)13.5%17.2%0.6126.1%
Gold (GLD)18.6%18.6%0.812.8%
Commodities (DBC)8.2%19.6%0.311.5%
Real Estate (VNQ)2.3%18.9%0.0223.3%
Bitcoin (BTCUSD)8.8%53.0%0.3511.9%

Smart multi-asset allocation framework can stack odds in your favor. Learn How
Based On 10-Year Data
Annualized
Return
Annualized
Volatility
Sharpe
Ratio
Correlation
with DLHC
DLHC-0.2%49.7%0.19-
Sector ETF (XLI)14.2%20.0%0.6220.4%
Equity (SPY)15.4%17.9%0.7320.4%
Gold (GLD)12.1%16.2%0.613.5%
Commodities (DBC)7.4%18.0%0.335.1%
Real Estate (VNQ)4.8%20.7%0.2020.8%
Bitcoin (BTCUSD)58.2%66.2%0.986.0%

Smart multi-asset allocation framework can stack odds in your favor. Learn How

Short Interest

Short Interest: As Of Date7152026
Short Interest: Shares Quantity0.1 Mil
Short Interest: % Change Since 6302026-27.6%
Average Daily Volume0.0 Mil
Days-to-Cover Short Interest1.7 days
Basic Shares Quantity14.5 Mil
Short % of Basic Shares0.4%

Earnings Returns History

Updated 8/7/2026
Expand for More
 Forward Returns
Earnings Date1D Returns5D Returns21D Returns
7/29/2026-9.3%-10.4% 
5/6/20262.3%-1.8%-0.4%
2/9/2026-4.8%-5.8%-2.6%
8/6/2025-0.2%-0.9%5.2%
5/7/20250.7%18.8%35.8%
2/5/2025-12.3%-17.6%-27.7%
11/13/20240.9%-4.0%-13.2%
7/31/2024-10.2%-14.8%-6.9%
...
SUMMARY STATS   
# Positive121210
# Negative131314
Median Positive1.3%3.8%9.5%
Median Negative-5.6%-5.8%-8.4%
Max Positive4.0%18.8%49.5%
Max Negative-18.8%-17.6%-27.7%
Collapse to Preview
 Forward Returns
Earnings Date1D Returns5D Returns21D Returns
7/29/2026-9.3%-10.4% 
5/6/20262.3%-1.8%-0.4%
2/9/2026-4.8%-5.8%-2.6%
8/6/2025-0.2%-0.9%5.2%
5/7/20250.7%18.8%35.8%
2/5/2025-12.3%-17.6%-27.7%
11/13/20240.9%-4.0%-13.2%
7/31/2024-10.2%-14.8%-6.9%
5/1/20244.0%5.9%9.0%
1/31/20240.6%3.9%-4.1%
12/6/2023-1.7%-3.8%9.6%
8/2/20232.1%3.9%6.7%
5/3/20233.0%0.7%12.8%
2/8/20230.5%-0.8%-11.7%
12/5/2022-2.5%3.2%-15.0%
8/2/20220.0%-5.5%-9.1%
5/4/2022-7.0%0.4%9.4%
1/31/2022-18.8%-11.5%-6.2%
12/6/20211.1%16.1%49.5%
8/4/20211.8%4.7%9.3%
5/5/20211.6%1.8%21.7%
2/2/2021-4.0%0.9%-7.7%
12/7/2020-5.6%-7.1%-9.9%
10/7/2020-2.7%3.7%-2.6%
8/5/2020-5.6%-15.9%-21.5%
SUMMARY STATS   
# Positive121210
# Negative131314
Median Positive1.3%3.8%9.5%
Median Negative-5.6%-5.8%-8.4%
Max Positive4.0%18.8%49.5%
Max Negative-18.8%-17.6%-27.7%

SEC Filings

Expand for More
Report DateFiling DateFiling
06/30/202607/29/202610-Q
03/31/202605/06/202610-Q
12/31/202502/09/202610-Q
09/30/202512/10/202510-K
06/30/202508/06/202510-Q
03/31/202505/09/202510-Q
12/31/202402/05/202510-Q
09/30/202412/04/202410-K
06/30/202407/31/202410-Q
03/31/202405/01/202410-Q
12/31/202301/31/202410-Q
09/30/202312/06/202310-K
06/30/202308/02/202310-Q
03/31/202305/03/202310-Q
12/31/202202/08/202310-Q
09/30/202212/05/202210-K
Collapse to Preview
Report DateFiling DateFiling
06/30/202607/29/202610-Q
03/31/202605/06/202610-Q
12/31/202502/09/202610-Q
09/30/202512/10/202510-K
06/30/202508/06/202510-Q
03/31/202505/09/202510-Q
12/31/202402/05/202510-Q
09/30/202412/04/202410-K
06/30/202407/31/202410-Q
03/31/202405/01/202410-Q
12/31/202301/31/202410-Q
09/30/202312/06/202310-K
06/30/202308/02/202310-Q
03/31/202305/03/202310-Q
12/31/202202/08/202310-Q
09/30/202212/05/202210-K
06/30/202208/02/202210-Q
03/31/202205/04/202210-Q
12/31/202101/31/202210-Q
09/30/202112/06/202110-K
06/30/202108/04/202110-Q
03/31/202105/05/202110-Q
12/31/202002/02/202110-Q
09/30/202012/07/202010-K
06/30/202008/05/202010-Q
03/31/202005/06/202010-Q
12/31/201902/05/202010-Q
09/30/201912/11/201910-K

Recent Forward Guidance

Updated 7/31/2026

Latest: Q3 2026 Earnings Reported 7/29/2026

Forward GuidanceGuidance Change
MetricLowMidHigh% Chg% DeltaChangePrior
Q4 2026 Adjusted EBITDA Margin 7.6%  0.0%Same NewActual: 7.6% for Q3 2026

null

Insider Activity

Updated 8/7/2026
Expand for More
#OwnerTitleHoldingActionFiling DatePriceSharesTransacted
Value
Value of
Held Shares
Form
1Mink, Brook Asset Management Llc Mink Brook Partners LPBuy80720264.831,0004,83110,502,763Form
2Mink, Brook Asset Management Llc Mink Brook Partners LPBuy80720264.819564,60110,458,381Form
3Mink, Brook Asset Management Llc Mink Brook Partners LPBuy80520264.841,0495,07510,510,040Form
4Mink, Brook Asset Management Llc Mink Brook Partners LPBuy80520264.874,00019,47710,571,837Form
5Mink, Brook Asset Management Llc Mink Brook Partners LPBuy73120264.864412,14510,541,091Form
Collapse to Preview
#OwnerTitleHoldingActionFiling DatePriceSharesTransacted
Value
Value of
Held Shares
Form
1Mink, Brook Asset Management Llc Mink Brook Partners LPBuy80720264.831,0004,83110,502,763Form
2Mink, Brook Asset Management Llc Mink Brook Partners LPBuy80720264.819564,60110,458,381Form
3Mink, Brook Asset Management Llc Mink Brook Partners LPBuy80520264.841,0495,07510,510,040Form
4Mink, Brook Asset Management Llc Mink Brook Partners LPBuy80520264.874,00019,47710,571,837Form
5Mink, Brook Asset Management Llc Mink Brook Partners LPBuy73120264.864412,14510,541,091Form
6Mink, Brook Asset Management Llc Mink Brook Partners LPBuy73120264.967,94439,39910,746,084Form
7Mink, Brook Asset Management Llc Mink Brook Partners LPBuy72820265.09105110,989,106Form
8Mink, Brook Asset Management Llc Mink Brook Partners LPBuy72420265.103911,99411,009,997Form
9Mink, Brook Asset Management Llc Mink Brook Partners LPBuy72420265.107940311,003,255Form
10Mink, Brook Asset Management Llc Mink Brook Partners LPBuy71420265.094,40722,44310,992,275Form
11Mink, Brook Asset Management Llc Mink Brook Partners LPBuy70820265.142,27511,70311,029,755Form
12Mink, Brook Asset Management Llc Mink Brook Partners LPBuy70820265.175,00025,85611,075,666Form
13Mink, Brook Asset Management Llc Mink Brook Partners LPBuy70620265.199,42248,88211,085,922Form
14Mink, Brook Asset Management Llc Mink Brook Partners LPBuy70620265.255,64029,59711,163,831Form
15Mink, Brook Asset Management Llc Mink Brook Partners LPBuy63020265.254,54323,84811,137,629Form
16Mink, Brook Asset Management Llc Mink Brook Partners LPBuy63020265.256403,36011,115,263Form
17Mink, Brook Asset Management Llc Mink Brook Partners LPBuy62620265.2815,28080,60211,164,817Form
18Mink, Brook Asset Management Llc Mink Brook Partners LPBuy62620265.509,34351,38611,557,002Form
19Mink, Brook Asset Management Llc Mink Brook Partners LPBuy62420265.503,73920,56411,505,615Form
20Mink, Brook Asset Management Llc Mink Brook Partners LPBuy62420265.5011060511,485,050Form
21Mink, Brook Asset Management Llc Mink Brook Partners LPBuy62220265.506243,43211,484,446Form
22Mink, Brook Asset Management Llc Mink Brook Partners LPBuy62220265.506,46035,53011,481,014Form
23Mink, Brook Asset Management Llc Mink Brook Partners LPBuy61720265.502,73315,03211,445,484Form
24Mink, Brook Asset Management Llc Mink Brook Partners LPBuy61720265.503,85921,22411,430,452Form
25Mink, Brook Asset Management Llc Mink Brook Partners LPBuy61220265.501,7139,42211,409,228Form
26Mink, Brook Asset Management Llc Mink Brook Partners LPBuy60920265.507139011,399,806Form
27Mink, Brook Asset Management Llc Mink Brook Partners LPBuy60920265.504927011,399,416Form
28Mink, Brook Asset Management Llc Mink Brook Partners LPBuy60320265.507,49441,21711,399,146Form
29Mink, Brook Asset Management Llc Mink Brook Partners LPBuy52820265.503,22317,72611,357,929Form
30Mink, Brook Asset Management Llc Mink Brook Partners LPBuy52120265.501,5848,71211,340,202Form
31Mink, Brook Asset Management Llc Mink Brook Partners LPBuy52120265.5012066011,331,490Form
32Mink, Brook Asset Management Llc Mink Brook Partners LPBuy51920265.502,39713,18411,330,830Form
33Mink, Brook Asset Management Llc Mink Brook Partners LPBuy51920265.505,30429,17211,317,647Form
34Mink, Brook Asset Management Llc Mink Brook Partners LPBuy51420265.505122,81611,288,475Form
35Mink, Brook Asset Management Llc Mink Brook Partners LPBuy51420265.5068,547377,00811,285,659Form
36Mink, Brook Asset Management Llc Mink Brook Partners LPBuy40820265.501961,07810,908,650Form
37Mink, Brook Asset Management Llc Mink Brook Partners LPBuy22020265.508,04844,26410,907,572Form
38Mink, Brook Asset Management Llc Mink Brook Partners LPBuy21820265.5022,057121,31410,863,308Form
39Mink, Brook Asset Management Llc Mink Brook Partners LPBuy21820265.502,64214,53110,741,995Form
40Mink, Brook Asset Management Llc Mink Brook Partners LPBuy21320265.503191,75410,727,464Form
41Mink, Brook Asset Management Llc Mink Brook Partners LPBuy21320265.5013,57774,67410,725,710Form
42Mink, Brook Asset Management Llc Mink Brook Partners LPBuy121820255.507842910,623,388Form
43Mink, Brook Asset Management Llc Mink Brook Partners LPBuy121820255.5044,208243,14410,622,958Form
44Mink, Brook Asset Management Llc Mink Brook Partners LPBuy121220255.509245,08210,379,814Form
45Mink, Brook Asset Management Llc Mink Brook Partners LPBuy102120255.502021,11110,374,732Form
46Mink, Brook Asset Management Llc Mink Brook Partners LPBuy101720255.506453,54810,373,622Form
47Mink, Brook Asset Management Llc Mink Brook Partners LPBuy101720255.5016590810,370,074Form
48Mink, Brook Asset Management Llc Mink Brook Partners LPBuy100820255.5013,17672,46810,369,166Form
49Mink, Brook Asset Management Llc Mink Brook Partners LPBuy100820255.5010055010,296,698Form
50Mink, Brook Asset Management Llc Mink Brook Partners LPBuy91620255.5015,52385,37610,296,148Form
51Mink, Brook Asset Management Llc Mink Brook Partners LPBuy91620255.507440710,210,772Form
52Mink, Brook Asset Management Llc Mink Brook Partners LPBuy91220255.5016,73492,03710,210,365Form
53Mink, Brook Asset Management Llc Mink Brook Partners LPBuy91220255.502001,10010,118,328Form
54Mink, Brook Asset Management Llc Mink Brook Partners LPBuy90320255.501971,08410,117,228Form
55Mink, Brook Asset Management Llc Mink Brook Partners LPBuy82920255.5018199610,116,144Form
56Mink, Brook Asset Management Llc Mink Brook Partners LPBuy82920255.504462,45310,115,149Form
57Mink, Brook Asset Management Llc Mink Brook Partners LPBuy82720255.502212110,112,696Form
58Mink, Brook Asset Management Llc Mink Brook Partners LPBuy82720255.508374,60410,112,575Form
59Mink, Brook Asset Management Llc Mink Brook Partners LPBuy82720255.503361,84810,107,972Form
60Mink, Brook Asset Management Llc Mink Brook Partners LPBuy82220255.5010055010,106,124Form
61Mink, Brook Asset Management Llc Mink Brook Partners LPBuy82220255.5018,01699,08810,105,574Form
62Mink, Brook Asset Management Llc Mink Brook Partners LPBuy82020255.5014,15477,84710,006,486Form
63Mink, Brook Asset Management Llc Mink Brook Partners LPBuy82020255.5026,803147,4169,928,638Form
64Mink, Brook Asset Management Llc Mink Brook Partners LPBuy82020255.502,08311,4569,781,222Form
65Mink, Brook Asset Management Llc Mink Brook Partners LPBuy81420255.504,33523,8429,769,766Form
66Mink, Brook Asset Management Llc Mink Brook Partners LPBuy81420255.503169,745,923Form
67Mink, Brook Asset Management Llc Mink Brook Partners LPBuy81420255.503922,1569,745,906Form
68Mink, Brook Asset Management Llc Mink Brook Partners LPBuy81120255.5050,000275,0009,743,750Form
69Mink, Brook Asset Management Llc Mink Brook Partners LPBuy81120255.5026,563146,0969,468,750Form
70Mink, Brook Asset Management Llc Mink Brook Partners LPBuy80620255.509685,3249,322,654Form
71Mink, Brook Asset Management Llc Mink Brook Partners LPBuy80620255.502451,3489,317,330Form
72Mink, Brook Asset Management Llc Mink Brook Partners LPBuy80620255.504,68725,7789,315,982Form
Core Cache Last Updated: 8/7/2026